Enlargement of the clitoris.

Related StoriesMeat-rich diet may increase kidney cancers riskViralytics enters into scientific trial collaboration agreement with MSDNew RNA check of blood platelets may be used to detect location of cancer We believe these data underscoring the efficacy and security of our lead candidate tivozanib in sufferers with apparent cell RCC who had undergone a prior nephrectomy are essential, as this is actually the same patient population that is becoming studied in TIVO-1, our global Phase 3 scientific trial analyzing the efficacy of tivozanib compared to sorafenib, stated Tuan Ha-Ngoc, president and chief executive officer of AVEO.